CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Jun 9, 2017
Insider Transaction Report
Form 4
Salisbury Franklin Cary jr
Director
Transactions
- Award
Stock Options (Right to Buy)
2017-06-08+35,000→ 35,000 totalExercise: $1.01Exp: 2027-06-08→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]Stock option award will vest ratably quarterly to the end of one year.